215 related articles for article (PubMed ID: 25967146)
1. Quality of life and functioning in first-episode psychosis Chinese patients with different antipsychotic medications.
Lee EH; Hui CL; Lin JJ; Ching EY; Chang WC; Chan SK; Chen EY
Early Interv Psychiatry; 2016 Dec; 10(6):535-539. PubMed ID: 25967146
[TBL] [Abstract][Full Text] [Related]
2. Incidence of hospitalization and its associated factors in first-episode psychosis in Hong Kong.
Lee EH; Hui CL; Lin JX; Ching EY; Li SP; Leung WG; Chang WC; Chan SK; Chen EY
Early Interv Psychiatry; 2016 Jun; 10(3):263-6. PubMed ID: 25702936
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.
Lieberman JA; Tollefson G; Tohen M; Green AI; Gur RE; Kahn R; McEvoy J; Perkins D; Sharma T; Zipursky R; Wei H; Hamer RM;
Am J Psychiatry; 2003 Aug; 160(8):1396-404. PubMed ID: 12900300
[TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
6. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
Crespo-Facorro B; Pérez-Iglesias R; Ramirez-Bonilla M; Martínez-García O; Llorca J; Luis Vázquez-Barquero J
J Clin Psychiatry; 2006 Oct; 67(10):1511-21. PubMed ID: 17107241
[TBL] [Abstract][Full Text] [Related]
7. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine versus haloperidol treatment in first-episode psychosis.
Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
[TBL] [Abstract][Full Text] [Related]
9. Clinical and treatment-related determinants of subjective quality of life in patients with first-episode psychosis.
Kwong VW; Chang WC; Chan GH; Jim OT; Lau ES; Hui CL; Chan SK; Lee EH; Chen EY
Psychiatry Res; 2017 Mar; 249():39-45. PubMed ID: 28063397
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
Juncal-Ruiz M; Ramirez-Bonilla M; Gomez-Arnau J; Ortiz-Garcia de la Foz V; Suarez-Pinilla P; Martinez-Garcia O; Neergaard KD; Tabares-Seisdedos R; Crespo-Facorro B
Psychopharmacology (Berl); 2017 Sep; 234(17):2563-2570. PubMed ID: 28567698
[TBL] [Abstract][Full Text] [Related]
11. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
12. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Yıldız M; Osman E
Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
[TBL] [Abstract][Full Text] [Related]
13. Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine.
Mulsant BH; Gharabawi GM; Bossie CA; Mao L; Martinez RA; Tune LE; Greenspan AJ; Bastean JN; Pollock BG
J Clin Psychiatry; 2004 Dec; 65(12):1708-14. PubMed ID: 15641877
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of amisulpride in treating primary negative symptoms in first-episode psychosis: a pilot study.
Murphy BP; Stuart AH; Wade D; Cotton S; McGorry PD
Hum Psychopharmacol; 2006 Dec; 21(8):511-7. PubMed ID: 17066489
[TBL] [Abstract][Full Text] [Related]
15. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
16. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
Ostinelli EG; Hussein M; Ahmed U; Rehman FU; Miramontes K; Adams CE
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009412. PubMed ID: 29634083
[TBL] [Abstract][Full Text] [Related]
17. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
Bret P; Bonnet F; Bret MC; Jaffré A
Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
[TBL] [Abstract][Full Text] [Related]
18. Rate and risk factors of depressive symptoms in Chinese patients presenting with first-episode non-affective psychosis in Hong Kong.
Chang WC; Cheung R; Hui CL; Lin J; Chan SK; Lee EH; Chen EY
Schizophr Res; 2015 Oct; 168(1-2):99-105. PubMed ID: 26235752
[TBL] [Abstract][Full Text] [Related]
19. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
20. Measuring movements in adolescents with psychosis using the Microsoft Kinect sensor: a pilot study exploring a new tool for assessing aspects of antipsychotic-induced parkinsonism.
Rudå D; Einarsson G; Matthiassen JB; Correll CU; Jensen KG; Klauber DG; Richard CJ; Andersen ASS; Krøigaard S; Møllegaard Jepsen JR; Fagerlund B; Winge K; Clemmesen LKH; Pagsberg AK; Paulsen RR; Fink-Jensen A
Child Adolesc Ment Health; 2020 May; 25(2):79-94. PubMed ID: 32307841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
